Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance.

Aim: To investigate whether 7-d triple therapies are still valid in populations with low levels of resistance.

Methods: A total of 1106 Helicobacter pylori (H. pylori)-positive patients were divided into three groups, each of which received one type of 7-d triple therapy.